Healthcare

Global Estrogen Replacement Therapy Market

March 28, 2020
ID: SR/HC-14
Format:Pdf
Pages:220

Global Estrogen Replacement Therapy Market by Dosage Forms (Patches, Tablets, Gels/Creams, Suppositories, Implants And Injections), By Routes Of Administration (Oral, Topical, Subcutaneous Pellets, Injections, and Others), By End-User (Hospitals, Clinics, Pharmacy Store, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast from 2020 to 2027

Description

Global Estrogen Replacement Therapy Market Overview

Estrogen Replacement Therapy has been widely used in menopausal women to prevent osteoporosis and coronary heart disease. Estrogen replacement therapy has the following benefits. First, estrogen replacement therapy can significantly relieve the symptoms of the menopausal syndrome, such as facial hot flashes and night sweats. Secondly, estrogen replacement therapy is still the most effective treatment for vaginal and vulvar atrophy in menopausal women. It can improve the pain associated with sexual intercourse, one of the most common causes of sexual apathy in menopausal women. Topical application can achieve curative effects. It has also been found that topical applications can reduce the recurrence rate of urinary tract infections. There is clear evidence of estrogen replacement Therapy can prevent osteoporosis and fractures.

However, due to other more effective treatments for osteoporosis, such as Bisphosphonates, estrogen replacement therapy is no longer a first-line drug for preventing osteoporosis. In addition, estrogen replacement therapy also may reduce the incidence of colorectal cancer.

Global Estrogen Replacement Therapy Market Insights

Global Estrogen Replacement Therapy Market likely to grow with a noteworthy rate during the forecast period, 2020-2027. The surge in the population of post-menopausal women across the world will accelerate the growth of the global estrogen replacement therapy market in the upcoming periods. Additionally, growing awareness of post-menopausal issues among women, coupled with the growth in drug development for menopausal issues, will fuel the global estrogen replacement therapy market in the next few years. Moreover, the rise in the geriatric population across the world and the various kinds of hormonal changes in the female body predominantly gets affected by the natural process of aging will influence the global estrogen replacement therapy industry in estimated periods.

Menopausal women can ease the function of estrogen secretion such as hot flashes, sweating, dizziness, insomnia, irritability, nameless, vaginal dryness, loss of libido, etc. with autonomic disorders based. Furthermore, the swelling awareness about menopausal symptoms among women and the growing treatment opportunities would be projected to fuel the global estrogen replacement therapy market in the future periods. In addition, augmentation in demand to prevent osteoporosis, a consequence of lowered estrogen levels, will surge the global estrogen replacement therapy market in the expected periods.

Growth Driver

The growing demand for Estrogen Replacement Therapy to treat the symptoms of menopause

The average age of menopause in normal women is 51 years, and 95% of menopause occurs between 45 and 55 years. Menopause is associated with a significant reduction in ovarian estrogen production. Low post-menopausal estrogen levels may induce vasomotor symptoms (hot flashes), and eventually vulvar vaginal atrophy symptoms, including vaginal dryness and pain during intercourse, namely menopausal genitourinary syndrome (menopause). Estrogen is most effective in alleviating menopausal symptoms, mainly hot flashes, vaginal dryness, and pain during intercourse. Estrogen prevents thinning of the bones (osteoporosis) in menopausal women.

Dosages Form Segmental Analysis

Based on dosages form, the global Estrogen Replacement Therapy market classified into Patches, Tablets, Gels/Creams, Suppositories, Implants, and Injections. The Tablets segment predicted to lead the market by 2027, owing to the growing demand tablet ERT for safety concerns and effective long-term therapy. They can reduce or resolve troublesome symptoms of menopause and lower the risk of osteoporosis.

The gels/creams segment will drive attributable to estrogen creams absorbed through the skin and go directly into the bloodstream, and they are safer than oral estrogen.

Routes of Administration Segmental Analysis

Based on routes of administration, the global Estrogen Replacement Therapy market categorized into Oral, Topical, Subcutaneous Pellets, Injection, and Others. The Oral segment projected to dominate the market as oral is the most preferred option for the patients. It has more favorable effects on lipid profiles, increases sex hormone-binding globulin (SHBG), and increases cortisol-binding globulin. The Topical segment will influence as it is used to treat vaginal dryness, itching, and burning in women who are experiencing menopause.

End-User Segmental Analysis

Based on end-user, the global estrogen replacement therapy market classified into Hospitals, Clinics, Pharmacy stores, and Others. Hospitals segment projected to register a higher CAGR by 2027, on account of the surge in the number of women across the globe coupled with the rise in the number of menopausal affected women worldwide.

The clinics’ segment provides immediate medicines, and consultation, along with the clinics, helps in the early detection of diseases.

Region Segmental Analysis

Based on geography, the global Estrogen Replacement Therapy market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America estimated to occupy the lion’s market share by 2027, owing to the rising geriatric population, high awareness levels, and the surge in purchasing power of the people coupled with technological innovations in healthcare systems in these regions.

The Asia Pacific will drive increasing awareness levels and the rising focus of governments towards the eradication of hormonal deficiencies.

Competitor Analysis

Companies such as AbbVie, Inc., Bayer AG, Hisamitsu Pharmaceutical Co., Inc., Novartis AG, Novo Nordisk A/S, Orion Pharma AB, Pfizer, Inc., Meda Pharmaceuticals, Teva Pharmaceutical Industries Ltd. and TherapeuticsMD, Inc. are the key players in the Global Estrogen Replacement Therapy Market.

Key Stakeholders

Market research and consulting firms
Industry associations
Global Estrogen Replacement Therapy manufacturing firm
Research organizations and consulting companies
Organizations, associations, and alliances related to Estrogen Replacement Therapy
Regulatory bodies
Suppliers
Retailers

Report Attribute	Details
Market size value in 2020	USD 33.65 billion
Revenue forecast in 2027	USD 49.3 billion
Growth Rate	CAGR of 5.65% from 2020 to 2027
Historical data	2017-2019
Forecast period	2021 – 2027
Region covered	North America, Europe, Asia-Pacific, South America, and Middle East & Africa
Key companies Profiled	AbbVie, Inc., Novartis AG, Novo Nordisk A/S, Bayer AG, Hisamitsu Pharmaceutical Co., Inc., Orion Pharma AB, Pfizer, Inc., Meda Pharmaceuticals, Teva Pharmaceutical Industries Ltd. and TherapeuticsMD, Inc.

Recent Developments

In September 2021, Myovant Science & Pfizer Announced FDA Approval for Myfembri® used to manage pain associated with Endometriosis.
In August 2021, Teva Pharmaceuticals and MedinCell announced the acceptance from the US Food and Drug Administration of TV-46000/MDC-IRM used to treat schizophrenia.
In March 2021, Theramex announced the completion of decentralized procedure approval from the UK and EU countries for Bijuva® capsules for Hormone Replacement Therapy.

The objective of the Research

Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.

Market Modelling

By Dosage Forms

Patches
Tablets
Gels/Creams
Suppositories Implants
Injections

By Routes of Administration

Oral
Topical
Subcutaneous Pellets
Injections
Others

By End-User

Hospitals
Clinics
Pharmacy Store
Others

By Region

North America
Europe
Asia Pacific
South America
Middle East & Africa

Table Of Contents

Methodology

Request Sample

Frequently Asked Questions (FAQ):

What is the growth rate of the Global Estrogen replacement therapy?

The growth rate of the Global Estrogen replacement therapy is 5.65% from 2021 to 2027.

What is the size of the Global Estrogen replacement therapy?

The size of the Global Estrogen replacement therapy is USD 33.65 billion in 2020, which will reach USD 49.3 billion by 2027.

What are the growth drivers of the Global Estrogen replacement therapy?

Growing drug development for menopausal issues and an increased population of post-menopausal women are the growth drivers of the Global Estrogen replacement therapy.

Who are the end-users of the Estrogen replacement therapy products?

Hospitals, Clinics, Pharmacy Stores are the end-users of Estrogen replacement therapy products.

What is the competitive landscape of Global Estrogen replacement therapy?

AbbVie, Inc., Novartis AG, Novo Nordisk A/S, Bayer AG, Hisamitsu Pharmaceutical Co., Inc., Orion Pharma AB, Pfizer, Inc., Meda Pharmaceuticals, Teva Pharmaceutical Industries Ltd. and TherapeuticsMD, Inc. are the key players in the Global Estrogen replacement therapy.

Select License

We Accept

Analyst support

After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.

Customer satisfaction

According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.

Inimitable expertise

Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.

Assured quality

We have created a systematic way to determine standards and satisfy your expectations.

Instant delivery

Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.

Privacy policy

We understand the inkling of your privacy, we will never misuse your email address.

Custom research service

We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.

Quality & accuracy

We provide you with the accurate quality of the customized study of an exclusive report according to your research need.

Data visualization

As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.

Information security

We truly respect your privacy and promise to keep your personal and confidential information safe and secure.

Global Estrogen Replacement Therapy Market

Global Estrogen Replacement Therapy Market Overview

Global Estrogen Replacement Therapy Market Insights

Growth Driver

The growing demand for Estrogen Replacement Therapy to treat the symptoms of menopause

Dosages Form Segmental Analysis

Routes of Administration Segmental Analysis

End-User Segmental Analysis

Region Segmental Analysis

Competitor Analysis

Key Stakeholders

Recent Developments

The objective of the Research

Market Modelling

Report Content

Frequently Asked Questions (FAQ):

Select License

We Accept

Latest Reports

Why Choose Us

Quick Links

Industries We Serve

Contact Info

Check Discount %

Free Sample Report